A leukocyte homologue of the IL-8 receptor CXCR-2 mediates the accumulation of macrophages in atherosclerotic lesions of LDL receptor-deficient mice.

Chronic macrophage-mediated inflammation is central to atherosclerosis. A role of the monocyte chemotactic and activating C-C chemokine JE/monocyte chemotactic protein-1 has been proposed. However, the human C-X-C chemokines growth-regulated oncogene (GROalpha) and IL-8, and their shared receptor, CXCR-2, also can be expressed at sites of chronic inflammation. Because we detected CXCR-2 in the intima of human atherosclerotic lesions, we examined the role of leukocyte CXCR-2 expression in affecting lesion cellularity. Atherosclerosis-susceptible LDL receptor-deficient mice were irradiated, successfully repopulated with bone marrow cells that either lacked or expressed mIL-8RH (the homologue of CXCR-2), and fed an atherogenic diet for 16 wk. In recipients of mIL-8RH+/+ marrow, mIL-8RH colocalized with densely accumulated intimal MOMA-2 positive macrophages. In contrast, lesions in recipients of mIL-8RH-/- marrow lacked mIL-8RH, had little intimal MOMA-2 staining, and were less extensive. The mIL-8RH ligand KC/GROalpha was detected in the intima of all aortic atherosclerotic lesions. Thus, the capacity of leukocytes to express mIL-8RH, and associated intralesional expression of its ligands such as KC/GROalpha, mediated the intimal accumulation of macrophages in atherosclerotic lesions of LDL receptor-deficient mice.

[1]  A Daugherty,et al.  The effects of total lymphocyte deficiency on the extent of atherosclerosis in apolipoprotein E-/- mice. , 1997, The Journal of clinical investigation.

[2]  A. Tall,et al.  IFN-gamma potentiates atherosclerosis in ApoE knock-out mice. , 1997, The Journal of clinical investigation.

[3]  Wei Sha,et al.  Structural Identification by Mass Spectrometry of Oxidized Phospholipids in Minimally Oxidized Low Density Lipoprotein That Induce Monocyte/Endothelial Interactions and Evidence for Their Presence in Vivo * , 1997, The Journal of Biological Chemistry.

[4]  J. Frostegård,et al.  Platelet-activating factor and oxidized LDL induce immune activation by a common mechanism. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[5]  J. D. Smith,et al.  T and B lymphocytes play a minor role in atherosclerotic plaque formation in the apolipoprotein E-deficient mouse. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[6]  P. Ridker,et al.  Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. , 1997, The New England journal of medicine.

[7]  O. Götze,et al.  Chemoattractant receptors for interleukin‐8 and C5a: expression on peripheral blood leukocytes and differential regulation on HL‐60 and AML‐193 cells by vitamin D3 and all‐trans rètinoic acid , 1997, European journal of immunology.

[8]  A. Buda,et al.  Levels of expression of P-selectin, E-selectin, and intercellular adhesion molecule-1 in coronary atherectomy specimens from patients with stable and unstable angina pectoris. , 1997, The American journal of cardiology.

[9]  L. Curtiss,et al.  Role of leukocyte-specific LDL receptors on plasma lipoprotein cholesterol and atherosclerosis in mice. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[10]  A. Tall,et al.  IFN- g Potentiates Atherosclerosis in ApoE Knock-out Mice , 1997 .

[11]  Y. Xia,et al.  Identification of Two Rat Genes Orthologous to the Human Interleukin-8 Receptors* , 1996, The Journal of Biological Chemistry.

[12]  H. Broxmeyer,et al.  Involvement of Interleukin (IL) 8 receptor in negative regulation of myeloid progenitor cells in vivo: evidence from mice lacking the murine IL-8 receptor homologue , 1996, The Journal of experimental medicine.

[13]  P. Loetscher,et al.  The interleukin‐8 receptor B and CXC chemokines can mediate transendothelial migration of human skin homing T cells , 1996, European journal of immunology.

[14]  K. Matsushima,et al.  Detection of mouse IL‐8 receptor homologue expression on peripheral blood leukocytes and mature myeloid lineage cells in bone marrow , 1996, Journal of leukocyte biology.

[15]  P. Murphy,et al.  The CXC Chemokines Growth-regulated Oncogene (GRO) α, GROβ, GROγ, Neutrophil-activating Peptide-2, and Epithelial Cell-derived Neutrophil-activating Peptide-78 Are Potent Agonists for the Type B, but Not the Type A, Human Interleukin-8 Receptor* , 1996, The Journal of Biological Chemistry.

[16]  C. Cochrane,et al.  In vivo, in vitro, and molecular aspects of interleukin-8 and the interleukin-8 receptors. , 1996, The Journal of laboratory and clinical medicine.

[17]  P. Tipping,et al.  Interleukin-8 production by macrophages from atheromatous plaques. , 1996, Arteriosclerosis, thrombosis, and vascular biology.

[18]  A. Daugherty,et al.  Lymphocyte populations in atherosclerotic lesions of apoE -/- and LDL receptor -/- mice. Decreasing density with disease progression. , 1996, Arteriosclerosis, thrombosis, and vascular biology.

[19]  T. Shimokama,et al.  Inflammatory and immunological nature of atherosclerosis. , 1996, International journal of cardiology.

[20]  J. Lundahl,et al.  Monocyte and Neutrophil Adhesion to Matrix Proteins is Selectively Enhanced in the Presence of Inflammatory Mediators , 1996, Scandinavian journal of immunology.

[21]  J. Major,et al.  Oxidized LDL potentiates LPS‐induced transcription of the chemokine KC gene , 1996, Journal of leukocyte biology.

[22]  L. Demer,et al.  Cross-regulatory roles of interleukin (IL)-12 and IL-10 in atherosclerosis. , 1996, The Journal of clinical investigation.

[23]  A. Tall,et al.  Interleukin 8 Is Induced by Cholesterol Loading of Macrophages and Expressed by Macrophage Foam Cells in Human Atheroma (*) , 1996, The Journal of Biological Chemistry.

[24]  C. Mackay,et al.  Expression of monocyte chemoattractant protein‐1 and interleukin‐8 receptors on subsets of T cells: correlation with transendothelial chemotactic potential , 1996, European journal of immunology.

[25]  D. Taub,et al.  Chemokines and T lymphocyte activation: II. Facilitation of human T cell trafficking in severe combined immunodeficiency mice. , 1996, Journal of immunology.

[26]  G. Zimmerman,et al.  Inflammation as an early component of atherosclerosis and vascular damage--a role for P-selectin and platelet-activating factor. , 1996, Japanese circulation journal.

[27]  A. Ben-Baruch,et al.  Chemokines: progress toward identifying molecular targets for therapeutic agents. , 1996, Trends in biotechnology.

[28]  J. Norgauer,et al.  Expression and growth-promoting function of the IL-8 receptor beta in human melanoma cells. , 1996, Journal of immunology.

[29]  K. Motoyoshi,et al.  Macrophage colony-stimulating factor induces interleukin-8 production in human monocytes. , 1996, Experimental hematology.

[30]  D. Taub,et al.  Chemokines regulate T cell adherence to recombinant adhesion molecules and extracellular matrix proteins. , 1996, Journal of immunology.

[31]  Jennifer C. Lee,et al.  CXC Chemokines Bind to Unique Sets of Selectivity Determinants That Can Function Independently and Are Broadly Distributed on Multiple Domains of Human Interleukin-8 Receptor B , 1996, The Journal of Biological Chemistry.

[32]  P. Murphy,et al.  The CXC chemokines growth-regulated oncogene (GRO) alpha, GRObeta, GROgamma, neutrophil-activating peptide-2, and epithelial cell-derived neutrophil-activating peptide-78 are potent agonists for the type B, but not the type A, human interleukin-8 receptor. , 1996, The Journal of biological chemistry.

[33]  S. Kunkel.  Th1- and Th2-type cytokines regulate chemokine expression. , 1996, Biological signals.

[34]  N. Mukaida,et al.  Recombinant human growth-regulated oncogene-alpha induces T lymphocyte chemotaxis. A process regulated via IL-8 receptors by IFN-gamma, TNF-alpha, IL-4, IL-10, and IL-13. , 1995, Journal of immunology.

[35]  D. Taub,et al.  Granulocyte-Colony Stimulating Factor and Lipopolysaccharide Regulate the Expression of Interleukin 8 Receptors on Polymorphonuclear Leukocytes (*) , 1995, The Journal of Biological Chemistry.

[36]  E M Rubin,et al.  Quantitation of atherosclerosis in murine models: correlation between lesions in the aortic origin and in the entire aorta, and differences in the extent of lesions between sexes in LDL receptor-deficient and apolipoprotein E-deficient mice. , 1995, Journal of lipid research.

[37]  A. Richmond,et al.  Distributions of melanoma growth stimulatory activity of growth-regulated gene and the interleukin-8 receptor B in human wound repair. , 1995, The American journal of pathology.

[38]  P. Tipping,et al.  T helper cell infiltration and foam cell proliferation are early events in the development of atherosclerosis in cholesterol-fed rabbits. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[39]  W. Wood,et al.  Chemokine binding and activities mediated by the mouse IL-8 receptor. , 1995, Journal of immunology.

[40]  L. Curtiss,et al.  Treatment of severe hypercholesterolemia in apolipoprotein E-deficient mice by bone marrow transplantation. , 1995, The Journal of clinical investigation.

[41]  D. Kelvin,et al.  Promoter analysis of the human interleukin-8 receptor genes, IL-8RA and IL-8RB. , 1995, Immunobiology.

[42]  J. Witztum,et al.  T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[43]  H. Flad,et al.  IL-8 specifically binds to endothelial but not to smooth muscle cells. , 1995, Journal of immunology.

[44]  D. Taub,et al.  Modulation of IL‐8 receptor expression on purified human T lymphocytes is associated with changed chemotactic responses to IL‐8 , 1995, Journal of leukocyte biology.

[45]  E. Miller,et al.  Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[46]  S. Murakami,et al.  Expression of both types of human interleukin‐8 receptors on mature neutrophils, monocytes, and natural killer cells , 1995, Journal of leukocyte biology.

[47]  K. Murakami,et al.  Thrombin induces GRO alpha/MGSA production in human umbilical vein endothelial cells. , 1995, Thrombosis research.

[48]  A. Chuntharapai,et al.  Monoclonal antibodies detect different distribution patterns of IL-8 receptor A and IL-8 receptor B on human peripheral blood leukocytes. , 1994, Journal of immunology.

[49]  J. Qiao,et al.  Immune-deficient mice develop typical atherosclerotic fatty streaks when fed an atherogenic diet. , 1994, The Journal of clinical investigation.

[50]  L. F. Kolakowski,et al.  The murine interleukin 8 type B receptor homologue and its ligands. Expression and biological characterization. , 1994, The Journal of biological chemistry.

[51]  A. Lusis,et al.  Role of the GRO family of chemokines in monocyte adhesion to MM-LDL-stimulated endothelium. , 1994, The Journal of clinical investigation.

[52]  M. D. de Bruijn,et al.  Markers of mouse macrophage development detected by monoclonal antibodies. , 1994, Journal of immunological methods.

[53]  W. Wood,et al.  Neutrophil and B cell expansion in mice that lack the murine IL-8 receptor homolog. , 1994, Science.

[54]  D K Burns,et al.  Massive xanthomatosis and atherosclerosis in cholesterol-fed low density lipoprotein receptor-negative mice. , 1994, The Journal of clinical investigation.

[55]  R. Terkeltaub,et al.  Oxidized LDL induces monocytic cell expression of interleukin-8, a chemokine with T-lymphocyte chemotactic activity. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[56]  K. Matsushima,et al.  Human IL-10 is a chemoattractant for CD8+ T lymphocytes and an inhibitor of IL-8-induced CD4+ T lymphocyte migration. , 1993, Journal of immunology.

[57]  A. Lusis,et al.  Genetic control of inflammatory gene induction and NF-kappa B-like transcription factor activation in response to an atherogenic diet in mice. , 1993, The Journal of clinical investigation.

[58]  W. Pearce,et al.  Enhanced production of the chemotactic cytokines interleukin-8 and monocyte chemoattractant protein-1 in human abdominal aortic aneurysms. , 1993, American Journal of Pathology.

[59]  R. Ross.  The pathogenesis of atherosclerosis: a perspective for the 1990s , 1993, Nature.

[60]  R. Strieter,et al.  Interleukin-8 as a macrophage-derived mediator of angiogenesis. , 1992, Science.

[61]  L. Lasky,et al.  Selectins: interpreters of cell-specific carbohydrate information during inflammation. , 1992, Science.

[62]  G. Hansson,et al.  T lymphocytes in human atherosclerotic plaques are memory cells expressing CD45RO and the integrin VLA-1. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

[63]  R. Terkeltaub,et al.  Cartilage and joint inflammation. Regulation of IL-8 expression by human articular chondrocytes. , 1992, Journal of immunology.

[64]  A. J. Valente,et al.  Monocyte transmigration induced by modification of low density lipoprotein in cocultures of human aortic wall cells is due to induction of monocyte chemotactic protein 1 synthesis and is abolished by high density lipoprotein. , 1991, The Journal of clinical investigation.

[65]  M. Baggiolini,et al.  [Ca2+]i Changes and Respiratory Burst in Human Neutrophils and Monocytes Induced by NAP‐1/Interleukin‐8, NAP‐2, and gro/MGSA , 1991, Journal of leukocyte biology.

[66]  P. Libby,et al.  Expression of monocyte chemotactic protein and interleukin-8 by cytokine-activated human vascular smooth muscle cells. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[67]  A. Anisowicz,et al.  An NF-kappa B-like transcription factor mediates IL-1/TNF-alpha induction of gro in human fibroblasts. , 1991, Journal of immunology.

[68]  D. Steinberg,et al.  Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions. , 1991, Proceedings of the National Academy of Sciences of the United States of America.